Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients
Clinical trial NCT06032052 · RECRUITING
Trial details
- NCT number
- NCT06032052
- Sponsor
- Hubei Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-09-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.